Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT00616941 · COMPLETED

Trial details

NCT number: NCT00616941
Sponsor: Ludwig Institute for Cancer Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2008-03-01
Primary completion: 2011-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.